Philip McCarthy, MD

PrintE-mail
Professor of Oncology
Director, Blood & Marrow Transplant Program, Department of Medicine
Roswell Park Cancer Institute

Profile

Areas of Expertise: 
Blood Marrow Transplant
Hematologic Oncology
Acute and chronic leukemias
Aplastic Anemia
Hodgkin lymphoma (HL)
Multiple myeloma
Myelodysplastic syndromes
Non-Hodgkin lymphoma (NHL)
Testicular cancer

Research

Research Interests: 
Health effects of radiation exposure
Modulation of chemotherapy toxicity
Modulation of graft versus host disease
Blood and marrow stem cell isolation
Immune modulation after transplantation
Cancer immunotherapy
Preclinical models of bone marrow transplantation
Models for patient outcomes after blood and marrow transplantation

Background Information

Education and Training: 
MD - Tufts University School of Medicine, Boston, MA
Residency: 
Yale-New Haven Hospital, Yale University, New Haven, CT
Board Certification: 
Internal Medicine, American Board of Internal Medicine
Hematology, American Board of Internal Medicine
Medical Oncology, American Board of Internal Medicine
Fellowships: 
Brigham and Women’s Hospital, Harvard University, Boston, MA

Publications

Publications: 
  • Ballen KK, Litzow MR, Marks DI, Maziarz RT, McCarthy PL, Schiller G, Schouten HC, Roy V, Wiernik PH, Horowitz MM, Giralt SA, Kroger N, Hogan WJ, Shrestha S, Sobocinski KA, Zhang M-J, Bashey A, Bolwell BJ, Cervantes F, Devine SM, Gale RP, Gupta V, Hahn TE, Arora M. Outcome of transplantation for myelofibrosis. Biology of blood and marrow transplantation 2010; 16(3):358-367
  • Francis J, Spangenthal E, Cohen IL, McCarthy PL, Smiley S, Paplham P, Wang E, Wetzler M, Ahluwalia MS, Battiwalla M. Reversible cardiotoxicity with tyrosine kinase inhibitors. Clinical advances in hematology and oncology : H&O 2010; 8(2):128-132
  • Hahn T, Zhelnova E, Sucheston L, Demidova I, Savchenko V, Battiwalla M, Smiley SL, Ambrosone CB, McCarthy PL. A deletion polymorphism in glutathione-S-transferase mu (GSTM1) and/or theta (GSTT1) is associated with an increased risk of toxicity after autologous blood and marrow transplantation. Biology of blood and marrow transplantation 2010; 16(6):801-808
  • Hari PN, Loberiza F, Maiolino A, McCarthy PL, Milone G, Omondi N, Reece DE, Seftel M, Trigg M, Vesole D, Weiss B, Wiernik P, Lee SJ, Rizzo JD, LeMaistre CF, Lazarus HM, Majhail NS, Zhang M-J, Hassebroek A, Siddiqui F, Ballen K, Bashey A, Bird J, Freytes CO, Gibson J, Hale G, Holmberg L, Kamble R, Kyle RA, Mehta P. Race and outcomes of autologous hematopoietic cell transplantation for multiple myeloma. Biology of blood and marrow transplantation 2010; 16(3):395-402
  • Lazarus HM, Maziarz RT, McCarthy PL, Pavlovsky S, Rizzo JD, Shea TC, Schouten HC, Slavin S, Winter JN, van Besien K, Vose JM, Marks DI, Klumpp TR, Inwards DJ, Zhang M-J, Carreras J, Hayes-Lattin BM, Ataergin AS, Bitran JD, Bolwell BJ, Freytes CO, Gale RP, Goldstein SC, Hale GA, Hari PN. A comparison of HLA-identical sibling allogeneic versus autologous transplantation for diffuse large B cell lymphoma: a report from the CIBMTR. Biology of blood and marrow transplantation 2010; 16(1):35-45
  • P�rez WS, Litzow MR, Luger S, Marks DI, Maziarz RT, McCarthy PL, Pasquini MC, Phillips GL, Rizzo JD, Sierra J, Tallman MS, Lazarus HM, Keating A, Tarima S, Pérez WS, Bolwell BJ, Cairo MS, Camitta BM, Cutler CS, De Lima M, Dipersio JF, Gale RP, Weisdorf DJ. Allogeneic transplantation for therapy-related myelodysplastic syndrome and acute myeloid leukemia. Blood 2010; 115(9):1850-1857
  • Oliansky DM, PL, McCarthy Jr, Jones RB, Werner M, van Besien KW, Soiffer RJ, McLaughlin P, Leonard JP, Laport G, King J, Gordon LI, Hahn T. The role of cytotoxic therapy with hematopoietic stem cell transplantation in the treatment of follicular lymphoma: an evidence-based review. Biology of blood and marrow transplantation 2010; 16(4):443-468
  • Marks DI, Tallman MS, Szer J, Sabloff M, Rizzieri DA, McCarthy P, Lewis VA, Lazarus HM, Klumpp TR, Khoury HJ, Halter J, Gupta V, George B, Gale RP, Copelan E, Antin JH, Perez WS, Wang T, Weisdorf DJ. The outcome of full-intensity and reduced-intensity conditioning matched sibling or unrelated donor transplantation in adults with Philadelphia chromosome-negative acute lymphoblastic leukemia in first and second complete remission. Blood 2010; 116(3):366-374
  • Navarro WH, Pasquini MC, McCarthy PL, Marks DI, Moreb JS, Liesveld JL, Litzow MR, Lazarus HM, Juckett M, Ho VT, Hahn T, Gupta V, Frangoul H, Bolwell BJ, Ballen K, Logan BR, Agovi M-A, Rizzo JD. Obesity does not preclude safe and effective myeloablative hematopoietic cell transplantation (HCT) for acute myelogenous leukemia (AML) in adults. Biology of blood and marrow transplantation 2010; 16(10):1442-1450
  • Patel AV, Hahn T, Bogner PN, Loud PA, Brown K, Paplham P, Syta M, Battiwalla M, McCarthy PL. Fatal diffuse alveolar hemorrhage associated with sirolimus after allogeneic hematopoietic cell transplantation. Bone marrow transplantation 2010; 45(8):1363-1364
  • Yao S, Smiley SL, West K, Lamonica D, Battiwalla M, McCarthy PL, Hahn T. Accelerated bone mineral density loss occurs with similar incidence and severity, but with different risk factors, after autologous versus allogeneic hematopoietic cell transplantation. Biology of blood and marrow transplantation 2010; 16(8):1130-1137
  • Battiwalla M , Hepgur M , Pan D , McCarthy PL , Ahluwalia MS , Camacho SH , Starostik P , Wallace PK. Multiparameter flow cytometry for the diagnosis and monitoring of small GPI-deficient cellular populations. Cytometry. Part B, Clinical cytometry 2010; 78(5):348-356
  • Reece DE , Gajewski JL , Gibson J , Hale GA , Kumar S , Kyle RA , Lazarus HM , McCarthy PL , Paylovsky S , Roy V , Weisdorf DJ , Wiernik PH , Gale RP , Freytes CO , Vesole DH , Shrestha S , Zhang MJ , Perez WS , Dispenzieri A , Milone GA , Abidi M , Atkins H , Bashey A , Bredeson CN , Boza WB , Hari PN. Outcome of Patients With IgD and IgM Multiple Myeloma Undergoing Autologous Hematopoietic Stem Cell Transplantation: A Retrospective CIBMTR Study. Clinical lymphoma, myeloma and leukemia 2010; 10(6):458-463
  • Uberti JP, Davies SM, Finke J, Hale GA, Kollman C, McCarthy PL, Ratanatharathorn V, Ringden O, Weisdorf DJ, Copelan E, Chan KW, Agovi M-A, Tarima S, Haagenson M, Gandham S, Anasetti C, Baker KS, Bolwell BJ, Bornhauser M, Rizzo JD. Comparative analysis of BU and CY versus CY and TBI in full intensity unrelated marrow donor transplantation for AML, CML and myelodysplasia. Bone marrow transplantation 2011; 46(1):34-43
  • Oliansky DM, McCarthy PL Jr, Jones RB, Wolff SN, Vose J, Omel J, Lazarus HM, Irwin FD, Fisher RI, Czuczman M, Hahn T. The role of cytotoxic therapy with hematopoietic stem cell transplantation in the treatment of diffuse large B cell lymphoma: update of the 2001 evidence-based review. Biology of blood and marrow transplantation 2011; 17(1):20-47.e30
  • Loren AW, Savani BN, McCarthy PL, Jakubowski AA, Kamani NR, Hayes-Lattin B, Maziarz RT, Warwick AB, Sorror ML, Bolwell BJ, Socie G, Wingard JR, Rizzo JD, Lazarus HM, Schouten HC, Cahn J-Y, Chow E, Jacobsohn DA, Gilleece M, Halter J, Joshi S, Wang Z, Sobocinski KA, Gupta V, Hale GA, Marks DI, Stadtmauer EA, Apperley J, Majhail NS. Pregnancy after Hematopoietic Cell Transplantation: A Report from the Late Effects Working Committee of the Center for International Blood and Marrow Transplant Research (CIBMTR). Biology of blood and marrow transplantation 2011; 17(2):157-166
  • Akpek G, Popat U, Carabasi M, Bornhaeuser M, Bolwell BJ, Ringden O, Ballen KK, Rizzo JD, McCarthy PL, Maharaj D, Marks DI, Pasquini MC, Agovi M, Logan B, Cooke KR, Maziarz RT, Gupta V, Lazarus HM, Hale GA, Ho VT. Spleen status and engraftment after allogeneic hematopoietic stem cell transplantation (HCT). Blood 2010; 116(21):3486
  • Weisdorf DJ, Stiff PJ, Halter J, Savoie ML, Sierra J, Stockerl-Goldstein KE, Cairo MS, Miller AM, Camitta B, Bartolomeo PD, Nabhan C, Jakubowski AA, Soiffer R, Bredeson CN, Marks DI, Lewis VA, Bornhauser M, Maziarz R, Devine SM, Petersdorf EW, Bunjes D, Isola LM, Antin JH, Lazarus HM, Liesveld JL, Litzow MR, Waller EK, Cin PD, Klumpp TR, Kim H, Zhang M, Perez W, Artz A, Gupta V, Rowe JM, Cutler C, Aljurf M, Ball ED, Finke J, Schouten H, Cahn J, McCarthy PL, Savani BN, Armand P. Cytogenetics abnormalities predict the outcome of allogeneic transplantation in AML: A CIBMTR study. Blood 2010; 116(21):680
  • Hahn T, McCarthy PL, Hassebroek A, Klein JP, Rizzo JD, Parsons S, Joffe S, Majhail NS. Significant improvement in day 100 and 1-year overall survival in patients who underwent myeloablative allogeneic hematopoietic cell transplant in the US or canada between 1994 and 2005. Blood 2010; 116(21):3509
  • Jagasia M, Gupta V, Haagenson MD, Horowitz MM, Lee SJ, Litzow MR, Pavletic SZ, Urbano A, Weisdorf DJ, Zhang M, Gale RP, Cutler C, Arora M, Flowers M, Chao NJ, McCarthy PL, Antin JH, Bolwell BJ, Bredeson C, Cahn J, Cairo MS, Hahn T. Risk-factors for acute graft-versus-host disease and survival after hematopoietic cell transplantation from siblings and unrelated donors - an analysis of the CIBMTR. Blood 2010; 116(21):897
  • McCarthy PL, Hahn T, Hassebroek A, Klein JP, Rizzo JD, Parsons S, Joffe S, Majhail NS. Significant improvement in overall survival in patients who underwent autologous hematopoietic cell transplant in the US or canada between 1994 and 2005. Blood 2010; 116(21):2389
  • McCarthy PL, Qazilbash MH, Levitan D, McClune B, Hars V, Postiglione J, Jiang C, Bennett E, Barry SS, Bressler L, Kelly M, Sexton M, Rosenbaum C, Parameswaran H, Pasquini MC, Horowitz MM, Shea TC, Devine SM, Martin T, Landau H, Bashey A, Owzar K, Anderson KC, Hofmeister CC, Hurd DD, Hassoun H, Giralt S, Stadtmauer EA, Richardson PG, Weisdorf DJ, Vij R, Moreb JS, Callander NS, Van Besien K, Gentile T, Isola L, Maziarz RT, Gabriel DA, Linker C. Phase III intergroup study of lenalidomide versus placebo maintenance therapy following single autologous hematopoietic stem cell transplantation (AHSCT) for multiple myeloma: CALGB 100104. Blood 2010; 116(21):37
  • McCarthy PL, Linker CA, Hars V, Giralt S, Stadtmauer EA, Hurd DD, Hassoun H, Hofmeister CC, Anderson KC, Owzar K, for CALGB ECOG and BMT-CTN . Phase III intergroup study of lenalidomide versus placebo maintenance therapy following single autologous stem cell transplant (ASCT) for multiple myeloma (MM): CALGB 100104. Journal of clinical oncology 2010; 28(15 Suppl.):8017
  • Almyroudis NG, Fabian J, Hahn T, Segal BH, Wetzler M, McCarthy Jr PL. Late infectious complications after cord blood stem cell transplantation. European journal of clinical microbiology and infectious diseases 2009; 28(11):1405-1408
  • Baker KS, Lazarus HM, LeMaistre CF, Loberiza F, Maharaj D, McCarthy P, Setterholm M, Spellman S, Trigg M, Maziarz RT, Switzer G, Lee SJ, Hale G, Hahn T, Davies SM, Majhail NS, Hassebroek A, Klein JP, Ballen KK, Bigelow CL, Frangoul HA, Hardy CL, Bredeson C, Dehn J, Friedman D, Rizzo JD. Race and socioeconomic status influence outcomes of unrelated donor hematopoietic cell transplantation. Biology of blood and marrow transplantation 2009; 15(12):1543-1554
  • Battiwalla M, McCarthy PL. Filgrastim support in allogeneic HSCT for myeloid malignancies: a review of the role of G-CSF and the implications for current practice. Bone marrow transplantation 2009; 43(5):351-356
  • Francis J, Loud P, Lamonica D, Syta M, Brown K, Paplham P, Bshara W, Barcos M, Wetzler M, Battiwalla M, Smiley S, McCarthy P. Detection of extra-medullary relapse of acute lymphoblastic leukemia by radiographic imaging following allogeneic hematopoietic SCT. Bone marrow transplantation 2009; 44(12):827-828
  • Giralt S, Vesole DH, Somlo G, Krishnan A, Stadtmauer E, Mccarthy P, Pasquini MC. Re: Tandem vs single autologous hematopoietic cell transplantation for the treatment of multiple myeloma: A systematic review and meta-analysis. Journal of the National Cancer Institute 2009; 101(13):964; author reply 966-7
  • Hahn T, Yao S, Dunford LM, Thomas J, Lohr J, Arora P, Battiwalla M, Smiley SL, McCarthy Jr PL. A comparison of measured creatinine clearance versus calculated glomerular filtration rate for assessment of renal function before autologous and allogeneic BMT. Biology of blood and marrow transplantation 2009; 15(5):574-579
  • Hari PN, Lazarus HM, McCarthy PL, Milone GA, Pavlovsky S, Reece DE, Schiller G, Vela-Ojeda J, Weisdorf D, Kyle RA, Gibson J, Zhang M-J, Roy V, Perez WS, Bashey A, To LB, Elfenbein G, Freytes CO, Gale RP, Vesole D. Is the International Staging System superior to the Durie-Salmon staging system? A comparison in multiple myeloma patients undergoing autologous transplant. Leukemia 2009; 23(8):1528-1534
  • Jones RB, Nieto Y, Wall D, Wingard JR, Rizzo JD, McCarthy Jr PL, Oliansky D, Hahn T. Methodology for updating published evidence-based reviews evaluating the role of blood and marrow transplantation in the treatment of selected diseases: a policy statement by the American Society for Blood and Marrow Transplantation. Biology of blood and marrow transplantation 2009; 15(6):761-762
  • Khuhchandani S, McCarthy PL, Cheney R, Hahn T, Syta M, Brown K, Paplham P, Battiwalla M, Smiley SL, Deeb G, Hong F. Fatal hyperacute graft-versus-host disease following denileukin diftitox treatment for recurrent t cell lymphoma after allogeneic stem cell transplantation. Biology of blood and marrow transplantation 2009; 15(7):887-890
  • Marks DI, Seftel M, Schouten HC, Ringden O, McCarthy PL, Ho V, Gupta V, Burns LJ, Bacigalupo A, Sobocinski KA, Wang Z, Logan BR, Ballen K, Rizzo JD. The effect of smoking on allogeneic transplant outcomes. Biology of blood and marrow transplantation 2009; 15(10):1277-1287
  • Martin PJ, MacMillan ML, Shpall EJ, Kebriaei P, Chao NJ, Weisdorf D, Schuster MW, Uberti JP, Szabolcs P, McCarthy PL, Klingemann H-G, Bachier CR, Soiffer RJ. Endpoints for clinical trials testing treatment of acute graft-versus-host disease: a joint statement. Biology of blood and marrow transplantation 2009; 15(7):777-784
  • Oliansky DM, McCarthy Jr PL, Jones RB, Silverman LR, Potts RG, Gore SD, de Lima M, Heptinstall KV, Engelhardt C, Deeg HJ, Bennett JM, Antin JH, Hahn T. The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of myelodysplastic syndromes: an evidence-based review. Biology of blood and marrow transplantation 2009; 15(2):137-172
  • Ringden O, Litzow MR, Locatelli F, Marks DI, McCarthy PL, Cowan MJ, Petersdorf EW, Russell JA, Schiller GJ, Schouten H, Spellman S, Verdonck LF, Wingard JR, Horowitz MM, Jagasia M, Halter J, Hale GA, Pavletic SZ, Anasetti C, Barrett AJ, Wang T, Wang D, Antin JH, Di Bartolomeo P, Bolwell BJ, Bredeson C, Cairo MS, Gale RP, Gupta V, Hahn T, Arora M. The graft-versus-leukemia effect using matched unrelated donors is not superior to HLA-identical siblings for hematopoietic stem cell transplantation. Blood 2009; 113(13):3110-3118
  • Stiff P, Micallef I, McCarthy P, Magalhaes-Silverman M, Weisdorf D, Territo M, Badel K, Calandra G. Treatment with plerixafor in non-Hodgkin's lymphoma and multiple myeloma patients to increase the number of peripheral blood stem cells when given a mobilizing regimen of G-CSF: implications for the heavily pretreated patient. Biology of blood and marrow transplantation 2009; 15(2):249-256
  • Varadarajan P, Hahn T, Smiley S, Battiwalla M, Padmanabhan S, Schiff M, Syta M, Paplham P, Brown K, Thomas JA, Dunford LM, McCarthy Jr PL. Seeing what's out of sight: wireless capsule endoscopy's unique ability to visualize and accurately assess the severity of gastrointestinal graft-versus-host-disease. Biology of blood and marrow transplantation 2009; 15(5):643-648
  • Weisdorf DJ, Gratwohl A, Khoury HJ, McCarthy P, Marks DI, Szer J, Woolfrey A, Cortes-Franco J, Horowitz MM, Gale R, Copelan E, Nelson G, Lee SJ, Haagenson M, Spellman S, Antin JH, Bolwell B, Cahn J-Y, Cervantes F, Arora M. Sibling versus unrelated donor allogeneic hematopoietic cell transplantation for chronic myelogenous leukemia: refined HLA matching reveals more graft-versus-host disease but not less relapse. Biology of blood and marrow transplantation 2009; 15(11):1475-1478
  • Horan JT, Rizzo JD, Smith FO, McCarthy PL, Martino R, Litzow MR, Juckett MB, Khoury HJ, Hale GA, Gupta V, Carabasi MH, Bredeson CN, Ballen KK, Bacigalupo AA, Lazarus HM, Agovi-Johnson M-A, Logan BR, Pasquini MC. Reducing the risk for transplantation-related mortality after allogeneic hematopoietic cell transplantation: how much progress has been made? . Journal of clinical oncology 2011; 29(7):805-813
  • McCarthy PL, Hahn T. Self-determinism: alloBMT for AML. Blood 2011; 117(7):2080-2081
  • Woolfrey A, Hurley CK, Marino S, McCarthy P, Orchard P, Oudshoorn M, Pollack MS, Reddy V, Shaw PJ, Spellman SR, Hale GA, Gupta V, Gajewski, Horan J, Wang T, Haagenson M, Ayas M, Baxter-Lowe LA, Bielorai B, Davies S, Dehn J, Frangoul H, Lee SJ. Evaluation of HLA matching requirements in unrelated hematopoietic stem cell transplantation for nonmalignant disorders. Biology of blood and marrow transplantation 2011; 17(Suppl. 2):56
  • Almyroudis NG, Wetzler M, McCarthy PL Jr, Wang ES, Wongkittiroch K, Hazamy PA, Samonis G, Hahn T, Lesse AJ, Segal BH. Molecular epidemiology and risk factors for colonization by vancomycin-resistant Enterococcus in patients with hematologic malignancies. Infection control and hospital epidemiology 2011; 32(5):490-496
  • Bashey A, Shea TC, Lister J, McCarthy P, Ball E, Hurd D, Farag S, Devine S, Baxter-Lowe LA, Kelly M, Edwards PS, Johnson JL, Owzar K, Linker C. Reduced-intensity conditioning allogeneic hematopoietic cell transplantation for patients with hematologic malignancies who relapse following autologous transplantation: a multi-institutional prospective study from the Cancer and Leukemia Group B (CALGB trial 100002). Biology of blood and marrow transplantation 2011; 17(4):558-565
  • Fleischhauer K, Miklos D, Oudshoorn M, Pollack MS, Marino S, Reddy V, Senitzer D, Shaw B, Waller EK, McCarthy P, Lee SJ, Heemskerk MB, Spellman SR, Wang T, Haagenson M, Battiwalla M, Baxter-Lowe LA, Dehn JW, Gajewski JL, Hale GA, Fernandez-Vina M. Non-permissive HLA-DPB1 T-cell epitope disparities are associated with non-relapse mortality after unrelated stem cell transplantation and are not dependent on HLA-DPA1. Bone marrow transplantation 2011; 46(Suppl. 1):S74
  • Fleischhauer K, McCarthy PL, Miklos DB, Oudshoorn M, Pollack MS, Marino S, Reddy V, Senitzer D, Shaw B, Waller EK, Lee SJ, Heemskerk MB, Wang T, Spellman SR, Crivello P, Haagenson M, Battiwalla M, Baxter-Lowe LA, Dehn JW, Gajewski JL, Hale GA, Fernandez-Vina M. No apparent contribution of HLA-DPA1 to the significantly increased risk for non-relapse mortality associated with non-permissive donor-recipient HLA-DPB1 T cell epitope disparities in unrelated stem cell transplants facilitated through the National Marrow Donor Program. Tissue antigens 2011; 77(5):397-398
  • Hepgur M, Bullard Dunn KM, Hahn TE, Loud PA, Schiff MD, Liu H, Thomas J, Anne N, Ahluwalia MS, McCarthy PL Jr. Medical management of pneumatosis intestinalis in patients undergoing allogeneic blood and marrow transplantation. Bone marrow transplantation 2011; 46(6):876-879
  • Moysich KB, McCarthy P, Hall P. 25 years after Chernobyl: lessons for Japan? . Lancet oncology 2011; 12(5):416-418
  • Valcarcel D, Senitzer D, Marino SR, Gajewski JL, Waller EK, Spellman SR, Setterholm M, Ringden O, Petersdorf EW, Oudshoorn M, McCarthy PL, Marks DI, Hale GA, Gupta V, Kan F, Wang T, Sierra J, Lee SJ. One-Antigen Mismatched Related versus HLA-Matched Unrelated Donor Hematopoietic Stem Cell Transplantation in Adults with Acute Leukemia: Center for International Blood and Marrow Transplant Research Results in the Era of Molecular HLA Typing. Biology of blood and marrow transplantation 2011; 17(5):640-648
  • Bashey A, Lazarus HM, Maharaj D, McCarthy PL, Milone GA, Nimer S, Pavlovsky S, Reece DE, Schiller G, Vesole DH, Hari P, Kyle RA, Giralt SA, Perez WS, Zhang MJ, Anderson KC, Ballen K, Berenson JR, To LB, Fonseca R, Freytes CO, Gale RP, Gibson J, Plasma Cell Disorders Working Committee. Comparison of twin and autologous transplants for multiple myeloma. Biology of blood and marrow transplantation 2008; 14(10):1118-1124
  • Benekli M, McCarthy PL Jr, Padmanabhan S, Battiwalla M, Bambach B, Hernandez-Ilizaliturri F, Czuczman MS, Younis T, Smiley SL, Hahn T. Intensive conditioning regimen of etoposide (VP-16), cyclophosphamide and carmustine (VCB) followed by autologous hematopoietic stem cell transplantation for relapsed and refractory Hodgkin's lymphoma. Bone marrow transplantation 2008; 41(7):613-619
  • Bishop MR, Horowitz MM, Giralt S, Loberiza FR Jr, Keating A, Milone G, Sierra J, Miller CB, Russell JA, McCarthy PL, Wiernik PH, Marks DI, Litzow MR, Lazarus HM, Cahn JY, Bolwell BJ, Gandham S, Logan BR, Weisdorf DJ. Long-term outcomes of adults with acute lymphoblastic leukemia after autologous or unrelated donor bone marrow transplantation: a comparative analysis by the National Marrow Donor Program and Center for International Blood and Marrow Transplant Research. Bone marrow transplantation 2008; 41(7):635-642
  • Hahn T, van Rood JJ, Gupta V, Halter J, Reddy V, Tiberghien P, Litzow M, Anasetti C, Pavletic S, Maziarz RT, Isola L, McCarthy PL Jr, Zhang MJ, Wang D, Arora M, Frangoul H, Gale RP, Hale GA, Horan J, Ringden O. Risk factors for acute graft-versus-host disease after human leukocyte antigen-identical sibling transplants for adults with leukemia. Journal of clinical oncology 2008; 26(35):5728-5734
  • Kumar S, Lacy MQ, Lazarus HM, McCarthy PL, Milone GA, Moreb JS, Pavlovsky S, Reece DE, Vesole DH, Wiernik PH, Kyle RA, Gibson J, Gale RP, Perez WS, Zhang MJ, Ballen K, Bashey A, To LB, Bredeson CN, Cairo MS, Elfenbein GJ, Freytes CO, Hari P. Comparable outcomes in nonsecretory and secretory multiple myeloma after autologous stem cell transplantation. Biology of blood and marrow transplantation 2008; 14(10):1134-1140
  • Lazarus HM, Pavlovsky S, Schouten HC, van Besien K, Vose JM, Bitran JD, Khouri IF, McCarthy PL, Yu H, Rowlings P, Serna DS, Horowitz MM, Rizzo JD, Miller AM, Marks DI, Carreras J, Boudreau C, Loberiza FR Jr, Armitage JO, Bolwell BJ, Freytes CO, Gale RP, Gibson J, Hale GA, Inwards DJ, LeMaistre CF, Maharaj D, Center For International Blood & Marrow Transplant Research (CIBMTR). Influence of age and histology on outcome in adult non-Hodgkin lymphoma patients undergoing autologous hematopoietic cell transplantation (HCT): a report from the Center For International Blood & Marrow Transplant Research (CIBMTR). Biology of blood and marrow transplantation 2008; 14(12):1323-1333
  • Lee SJ, Khoury HJ, George B, Hale GA, Liesveld JL, Rizzieri DA, Antin JH, Bolwell BJ, Carabasi MH, Copelan E, Ilhan O, Litzow MR, Schouten HC, Zander AR, Horowitz MM, Gupta V, Abecasis M, Stadtmauer EA, Kukreja M, Wang T, Giralt SA, Szer J, Arora M, Woolfrey AE, Cervantes F, Champlin RE, Gale RP, Halter J, Keating A, Marks DI, McCarthy PL, Olavarria E, Maziarz RT. Impact of prior imatinib mesylate on the outcome of hematopoietic cell transplantation for chronic myeloid leukemia. Blood 2008; 112(8):3500-3507
  • Marks DI, Klumpp TR, Lazarus HM, Liesveld JL, Maziarz RT, McCarthy PL, Sabloff M, Schiller G, Sierra J, Tallman MS, Waller EK, Wiernik PH, Keating A, Jakubowski AA, Perez WS, He W, Zhang MJ, Bishop MR, Bolwell BJ, Bredeson CN, Copelan EA, Gale RP, Gupta V, Hale GA, Isola LM, Weisdorf DJ. Unrelated donor transplants in adults with Philadelphia-negative acute lymphoblastic leukemia in first complete remission. Blood 2008; 112(2):426-434
  • Oliansky DM, McCarthy PL Jr, Tallman MS, Stone RM, Stewart S, Nieto Y, Kerr J, Keating A, Cassileth PA, Appelbaum F, Hahn T. The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of acute myelogenous leukemia in adults: an evidence-based review. Biology of blood and marrow transplantation 2008; 14(2):137-180
  • Schlenk RF, Lazarus HM, Liesveld JL, Litzow MR, Marks DI, Maziarz RT, McCarthy PL, Nimer SD, Sierra J, Tallman MS, Weisdorf DJ, Horowitz MM, Ganser A, Ilhan O, Gale RP, Dohner H, Pasquini MC, Perez WS, Zhang MJ, Krauter J, Antin JH, Bashey A, Bolwell BJ, Buchner T, Cahn JY, Cairo MS, Copelan EA, Cutler CS, CIBMTR Acute Leukemia Working Committee. HLA-identical sibling allogeneic transplants versus chemotherapy in acute myelogenous leukemia with t(8;21) in first complete remission: collaborative study between the German AML Intergroup and CIBMTR. Biology of blood and marrow transplantation 2008; 14(2):187-196
  • Smith SM, McCarthy PL, Navarro WH, Pavlovsky S, Schouten HC, Seftel M, Wiernik PH, Vose JM, Lazarus HM, Maziarz RT, Keating A, Holmberg LA, van Besien K, Carreras J, Bashey A, Cairo MS, Freytes CO, Gale RP, Hale GA, Hayes-Lattin B, Hari P. Second autologous stem cell transplantation for relapsed lymphoma after a prior autologous transplant. Biology of blood and marrow transplantation 2008; 14(8):904-912
  • Yao S, Padmanabhan S, Battiwalla M, Smiley S, Lamonica D, Syta M, Paplham P, Brown K, Roy DM, Dunford LM, McCarthy PL, Hahn T. High prevalence of early-onset osteopenia/osteoporosis after allogeneic stem cell transplantation and improvement after bisphosphonate therapy. Bone marrow transplantation 2008; 41(4):393-398
  • Battiwalla M, Hahn T, McCarthy PL Jr. HLA DR15 and immunobiologic outcomes. Biology of blood and marrow transplantation 2007; 13(3):371
  • Battiwalla M, McCarthy PL, Becker J, Smith P, Elefante A, Abdelhalim A, McCarthy A, Almyroudis NG, Paplham P, Segal BH. Leflunomide failure to control recurrent cytomegalovirus infection in the setting of renal failure after allogeneic stem cell transplantation. Transplant infectious disease 2007; 9(1):28-32
  • Battiwalla M, Hahn T, Padmanabhan S, Nakamura R, Wallace PK, Segal BH, Almyroudis NG, Radovic M, Bajwa RP, Wu Y, McCarthy PL Jr. Ganciclovir inhibits lymphocyte proliferation by impairing DNA synthesis. Biology of blood and marrow transplantation 2007; 13(7):765-770
  • Giralt SA, Arora M, Goldman JM, Lee SJ, Maziarz RT, McCarthy PL, Sobocinski KA, Horowitz MM, Chronic Leukemia Working Committee, Center for International Blood and Marrow Transplant Research. Impact of imatinib therapy on the use of allogeneic haematopoietic progenitor cell transplantation for the treatment of chronic myeloid leukaemia. British journal of haematology 2007; 137(5):461-467
  • Gupta S, Kwon-Chung J, Varma A, Paplham P, Ball D, Proefrock AD, McCarthy PL, Bambach BJ, Battiwalla M, Almyroudis NG, Segal BH. Successful treatment of disseminated fusariosis with posaconazole during neutropenia and subsequent allogeneic hematopoietic stem cell transplantation. Transplant infectious disease 2007; 9(2):156-160
  • Leising LK, McCarthy Jr PL, Hahn T, Dunford L, McKernon M. Bottled water myths: Separating fact from fiction. Practical gastroenterology 2007; 31(5):87-93
  • McCarthy PL. "Stimulate the phagocytes!" Fascin-ating! Are DCs actin' up? . Blood 2007; 109(10):4112-4113
  • Oliansky DM, McCarthy PL Jr, Wilmot F, Smith FO 3rd, Sanders JE, Ravindranath Y, Leone L, Arceci RJ, Aplan PD, Rizzo JD, Hahn T. The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of acute myeloid leukemia in children: an evidence-based review. Biology of blood and marrow transplantation 2007; 13(1):1-25
  • Padmanabhan S, Battiwalla M, Hahn T, Ball D, Paplham P, Brown K, Segal BH, McCarthy P Jr, Almyroudis NG. Two cases of hepatic zygomycosis in allogeneic stem cell transplant recipients and review of literature. Transplant infectious disease 2007; 9(2):148-152
  • Reddy NM, Sullivan MA, Hahn TE, Battiwalla M, Smiley SL, McCarthy PL. Association of squamous cell carcinoma of the oral cavity in allogeneic hematopoietic stem cell transplant recipients. Bone marrow transplantation 2007; 40(9):907-909
  • Aggarwal C, Gupta S, Hahn T, Smiley S, Padmanabhan S, McCarthy PL Jr, Battiwalla M. Human leukocyte antigen DR4 is associated with inferior progression-free survival following allogeneic hematopoietic stem cell transplantation for lymphoid malignancies. Leukemia and lymphoma 2008; 49(8):1494-1500
  • Koutros S, Holford TR, Hahn T, Lantos PM, McCarthy PL Jr, Risch HA, Swede H. Excess diagnosis of non-Hodgkin's lymphoma during spring in the USA. Leukemia and lymphoma 2007; 48(2):357-366
  • Badari A, Hahn T, Ross M, Liu H, Chen G, Liu J, Arnold K, Burgess M, Syta M, Paplham P, Brown K, McCarthy P. Managing cardiac amyloidosis: Auto or allotransplant? . American journal of hematology 2011; 86(10):885-886
  • Pukiat S, McCarthy PL, Hahn T, Morrison C, Shanahan T, Qiu J, Liu H. Sarcoidosis-associated MHC Ags and the development of cutaneous and nodal granulomas following allogeneic hematopoietic cell transplant. Bone marrow transplantation 2011; 46(7):1032-1034
  • Aggarwal C, Gupta S, McCarthy PL, Battiwalla M, Hahn TE. Human leukocyte antigen (HLA) haplotypes and single HLA antigens in HLA-matched allogeneic hematopoietic stem cell transplantation (alloHSCT) for myeloid diseases: Analysis of overall and progression free survival (OS/PFS). Biology of blood and marrow transplantation 2007; 13(2 Suppl. 2):40
  • Ashraf U, Mahajan R, Hahn T, Smiley SL, McCarthy PL, Bernstein ZP, Chanan-Khan AA, Battiwala M, Czuczman MS, Hernandez-Lizaliturri FJ. The Effects of Rituximab Added to Front-Line or Salvage Chemotherapy in Diffuse Large B-Cell Lymphoma (DLBCL) Undergoing High-Dose Chemotherapy (HDC) and Autologous Stem Cell Transplant (ASCT). Blood 2008; 112(11):415-416
  • Capitano ML, Mace T, McCarthy P, Repasky E. Mild (fever-range) thermal stress increases the rate of granulocyte recovery and G-CSF production following non-myeloablative total body irradiation. Journal of immunotherapy (Hagerstown, Md. : 1997) 2007; 30(8):867-868
  • Hahn T, McCarthy PL, Carreras J, Zhang MJ, Lazarus HM, Laport GG, Montoto S, Hari PN. Comparison of Prognostic Models for Autologous Hematopoietic Stem Cell Transplantation (AHCT) for Relapsed Hodgkin Lymphoma. Blood 2009; 114(22):499-500
  • Hahn T, Yao S, Smiley S, West K, Battiwalla M, Lamonica D, McCarthy PL. Clinical and Genetic Factors Underlying Acute Bone Mineral Density Loss by 100 Days after Blood and Marrow Transplantation: A Potential Early Regimen-Related Complication. Blood 2008; 112(11):26-27
  • Hahn T, Zhelnova E, Demidova I, Savchenko V, Ambrosone CB, McCarthy PL. Glutathione-S-Transferase M1 (GSTM1) and T1 (GSTT1) deletion polymorphisms predict regimen-related toxicity after autologous and allogeneic blood and marrow transplantation (BMT). Blood 2007; 110(11 Part 1):Abstract #1982
  • Horan J, Logan BR, Agovi MA, Lazarus HM, Bacigalupo A, Ballen K, Martino R, Juckett MB, Khoury HJ, Bredeson C, Gupta V, Smith FO, Hale G, Carabasi M, McCarthy PL, Rizzo JD, Pasquini MC. Reducing the Risk for Transplant Related Mortality After Allogeneic Hematopoietic Cell Transplantation: How Much Progress Has Been Made?. Blood 2009; 114(22):269-270
  • Jensen S, Dorsheimer K, Mignone-Klostermann T, McCarthy P. Blood and marrow transplant patient and family orientation: Patient profiles and program satisfaction. Psycho-oncology 2008; 17(3 Suppl.):S40
  • Macchio DM, Dubel KA, Lipka PE, Rieman CM, Hernandez LK, Casbaw AC, Bouquard AJ, Werder MJ, Smiley SI, Padmanabban S, Bartiwalla M, Hahn TE, Yasko JM, McCarthy PL. Development of a health insurance portability and accountability act (HIPAA) compliant customized electronic summary face sheet for coordination of care and data management needs available pre-hospital admission for each blood and marrow transplant (BMT) patient. Biology of blood and marrow transplantation 2007; 13(2 Suppl. 2):431
  • McCarthy PL, Owzar K, Stadtmauer EA, Giralt S, Hurd DD, Hassoun H, Hofmeister C, Richardson P, Weisdorf DJ, Pasquini MC, Hars V, Kelly M, Postiglione J, Sutherland S, Anderson KC, Linker C. Phase III Intergroup Study of Lenalidomide (CC-5013) Versus Placebo Maintenance Therapy Following Single Autologous Stem Cell Transplant for Multiple Myeloma (CALGB 100104): Initial Report of Patient Accrual and Adverse Events. Blood 2009; 114(22):1327
  • Navarro WH, Agovi MA, Logan B, Bacigalupo A, Ballen KK, Bolwell BJ, Frangoul H, Gupta V, Hahn T, Juckett M, Lazarus HM, Litzow MR, Liesveld J, Moreb J, Marks D, McCarthy PL, Rizzo JD. Obesity Does Not Preclude Safe and Effective Myeloablative Hematopoietic Cell Transplantation (HCT) for Acute Myeloid Leukemia (AML) in Adults. Blood 2008; 112(11):26
  • Padmanabhan S, Elefante A, Varadarajan P, Battiwaralla M, Bir A, Hahn T, Smiley S, Hernandez-Illizalitturi FJ, Miner L, Mohr A, Bernstein ZP, Chanan-Khan A, McCarthy P, Czuczman M. Outcomes of relapsed/refractory B-cell lymphoma is improved by salvage chemotherapy consisting of two to three cycles of dexamethasone (D), High Dose Ara-C (HA) and carboplatin (DHAC) with or without rituximab (R) followed by autologous stem cell transplantation. Blood 2007; 110(11 Part 2):364B-365B (Abstract #5130)
  • Pahk A, McCarthy P, Smiley S, Nava H, Yang G, Smith J, Trump D, Battiwalla M, Andrews C, Schiff M. Wireless Capsule Endoscopy as a Diagnostic Tool and Predictor of Acute and Chronic Graft-Versus-Host Disease. American journal of gastroenterology 2009; 104(Suppl. 3):Abstract #1354
  • Pawarode A, Hahn T, Battiwalla M, Paplham P, Smiley SL, McCarthy PL. Extracorporeal photopheresis for the treatment of steroid-refractory and -intolerant chronic graft-versus-host disease. Bone marrow transplantation 2008; 41(Suppl. 1):S235
  • Pawarode A, Hahn V, Battiwalla M, McCarthy PL. Extracorporeal photopheresis (ECP) for the treatment of steroid-refractory or -intolerant chronic graft-versus-host disease (cGvHD) following allogeneic hematopoietic stem cell transplant (HSCT). Biology of blood and marrow transplantation 2007; 13(2 Suppl. 2):318
  • Rathnasabapathy C, West K, Fetterly G, Battiwalla M, Smiley SL, Hahn T, Brown K, Arnold K, Syta M, Paplham P, Liu J, McCarthy PL. Pharmacokinetics of Mycophenolic Mofetil and Metabolites in Allogeneic Transplant: Determination of Maximum Dose Schedule and Route of Administration. Blood 2009; 114(22):897
  • Smiley SL, Hahn T, Tan W, Wilding G, Battiwalla M, McCarthy PL. BuCy Provides Equivalent Outcomes to VCyTBI as Conditioning Prior to Auto-SCT in Patients with Relapsed/Refractory NHL and Is a Valuable Option in Older (>= 60 years) Patients. Blood 2008; 112(11):759
  • Valcarcel D, Kan F, Wang T, Lee SJ, Spellman SR, Hale GA, Marino S, Marks D, McCarthy PL, Oudshoorn M, Petersdorf EW, Ringden O, Setterholm M, Sierra J. One Antigen HLA-Mismatched Related and 8/8 Allele Matched Unrelated Donors Are Associated with Similar Survival after Hematopoietic Cell Transplantation for Acute Leukemia. Blood 2008; 112(11):355
  • Varadarajan P, Battiwalla M, Smiley S, Schiff M, Hahn T, McCarthy PL. Wireless capsule endoscopy (WCE) is an important diagnostic and management tool of gastrointestinal (GI) acute and chronic graft versus host disease (GVHD) after allogeneic hematopoietic stem cell transplantation (AlloHSCT) and identifies gastroparesis as a prominent complication of GI GVHD. Blood 2007; 110(11 Part 1):Abstract #2985
  • Zeidan A, Tan W, Wilding G, Ford L, Hahn T, Smiley S, Battiwalla M, McCarthy PL, Wang ES, Wetzler M. Gemtuzumab Ozogamicin (GO) and Continuous Infusion Cytarabine (ARA-C) for Relapsed/Refractory Acute Myeloid Leukemia (AML) Prior to Allogeneic Stem Cell Transplantation (SCT). Blood 2008; 112(11):350-351
  • Zhelnova E, Hahn T, McCarthy P, Demidova I, Misiurin A, Parovitchnikova E, Savchenko V. Treatment-related toxicity after haematopoietic stem cell transplantation and deletion polymorphisms in glutathione-S-transferase M1 and glutathione-S-transferase T1 in different ethnic populations of patients. Bone marrow transplantation 2008; 41(Suppl. 1):S99
  • Lee HJ, Wright KM, Kandeel E, Tan W, Wilding GE, Ford LA, Sait SN, Block AMW, Barcos MP, McCarthy PL, Vigil CE, Griffiths EA, Thompson JE, Wang ES, Wallace PK, Wetzler M. The role of minimal residual disease (MRD) by flow cytometry (FC) in predicting outcome in similarly treated acute lymphoblastic leukemia (ALL) patients : ASCO Meeting Abstracts Part 1. Journal of clinical oncology 2011; 29(15 Suppl.):6592
  • Howard DH, Kenline C, Lazarus HM, Lemaistre CF, Maziarz RT, McCarthy Jr PL, Parsons SK, Szwajcer D, Douglas Rizzo J, Majhail NS. Abandonment of high-dose chemotherapy/hematopoietic cell transplants for breast cancer following negative trial results. Health services research 2011; 46(6pt1):1762-1777
  • McCarthy PL, Owzar K, Anderson K. Sowing dragon's teeth? Myeloma and AML. Blood 2011; 118(15):4008-4009
  • Vogl DT, Wang T, Perez WS, Stadtmauer EA, Heitjan DF, Lazarus HM, Kyle RA, Kamble R, Weisdorf D, Roy V, Gibson J, Ballen K, Holmberg L, Bashey A, McCarthy PL, Freytes C, Maharaj D, Maiolino A, Vesole D, Hari P. Effect of obesity on outcomes after autologous hematopoietic stem cell transplantation for multiple myeloma. Biology of blood and marrow transplantation 2011; 17(12):1765-1774
  • Yao S, Sucheston LE, Smiley SL, Davis W, Conroy JM, Nowak NJ, Ambrosone CB, McCarthy PL Jr, Hahn T. Common genetic variants are associated with accelerated bone mineral density loss after hematopoietic cell transplantation. PloS one 2011; 6(10):e25940
  • Oliansky DM, Larson RA, Weisdorf D, Dillon H, Ratko TA, Wall D, McCarthy PL Jr, Hahn T. The role of cytotoxic therapy with hematopoietic stem cell transplantation in the treatment of adult acute lymphoblastic leukemia: update of the 2006 evidence-based review. Biology of blood and marrow transplantation 2012; 18(1):18-36.e6
  • Giralt S, Stadtmauer E, McCarthy P. What did we learn in 2010 from the phase III trials? Is maintenance therapy the new standard for myeloma?. Biology of blood and marrow transplantation 2011; 17(1 Suppl.):S30-S32
  • Liu H, Hahn T, Wilding G, Groman A, Bambach B, Higman M, Ross M, Chen GL, McCarthy PL Jr. Fludarabine, Melphalan and Low Dose Total Body Irradiation for Reduced Intensity Conditioning (RIC) Prior to Allogeneic Hematopoietic Cell Transplantation (AlloHCT). Blood 2011; 118(21):4570
  • McCarthy P, Owzar K, Anderson K, Hofmeister C, Richardson P, Hassoun H, Stadtmauer E, Giralt S, Hurd D, Hars V, Jiang C, Postiglione J, Bressker L, Devine S, Linker C. Phase III Intergroup Study of Lenalidomide versus Placebo Maintenance Therapy Following Single Autologous Stem Cell Transplant (ASCT) for Multiple Myeloma (MM): CALGB ECOG BMT-CTN 100104. Haematologica 2011; 96(Suppl. 1):S23
  • Aplenc R, Pasquini MC, Zhang MJ, Zhu X, McCarthy PL, Ho VT, Cooke KR, Sung L, Bunin NJ. Effects of Body Mass Index (BMI) in Children Undergoing Allogeneic Bone Marrow Transplant (BMT) for Hematologic Malignancies. Biology of blood and marrow transplantation 2012; 18(2 Suppl.):S230
  • Armand P, Kim HT, Zhang M-J, Perez WS, Dal Cin PS, Klumpp TR, Waller EK, Litzow MR, Liesveld JL, Lazarus HM, Artz AS, Gupta V, Savani BN, McCarthy PL, Cahn J-Y, Schouten HC, Finke J, Ball ED, Aljurf MD, Cutler CS, Rowe JM, Antin JH, Isola LM, Di Bartolomeo P, Camitta BM, Miller AM, Cairo MS, Stockerl-Goldstein K, Sierra J, Savoie ML, Halter J, Stiff PJ, Nabhan C, Jakubowski AA, Bunjes DW, Petersdorf EW, Devine SM, Maziarz RT, Bornhauser M, Lewis VA, Marks DI, Bredeson CN, Soiffer RJ, Weisdorf DJ. Classifying cytogenetics in patients with acute myelogenous leukemia in complete remission undergoing allogeneic transplantation: a Center for International Blood and Marrow Transplant Research study. Biology of blood and marrow transplantation 2012; 18(2):280-288
  • Chen G, Hahn T, Zhang Y, Pan D, Brix L, Ross M, Liu H, Wallace P, McCarthy P. Quantifying Anti-Cytomegalovirus (CMV) Immunity with CMV Antigen Specific T Cells (Casts) After Allogeneic Hematopoietic Cell Transplant (alloHCT). Biology of blood and marrow transplantation 2012; 18(2 Suppl.):S274
  • Chen GL, Zhang YL, Liu H, Ross M, Hahn T, McCarthy PL. Micro Dose Methotrexate (MTX) Is Equivalent to Full Dose MTX and Superior to No MTX for Acute Graft-Versus-Host Disease Prophylaxis. Blood 2011; 118(21):1309-1310
  • Hahn T, McCarthy PL, Carreras J, Zhang MJ, Lazarus HM, Laport GG, Montoto S, Maloney DG, Hari P. A CIBMTR Prognostic Model for Progression-Free Survival (PFS) After Autologous Hematopoietic Cell Transplantation (AHCT) for Relapsed or Refractory Hodgkin Lymphoma (HL). Blood 2011; 118(21):232-233
  • Jagasia M, Arora M, Flowers MED, Chao NJ, McCarthy PL, Cutler CS, Urbano-Ispizua A, Pavletic SZ, Haagenson MD, Zhang M-J, Antin JH, Bolwell BJ, Bredeson C, Cahn J-Y, Cairo M, Gale RP, Gupta V, Lee SJ, Litzow M, Weisdorf DJ, Horowitz MM, Hahn T. Risk factors for acute GVHD and survival after hematopoietic cell transplantation. Blood 2012; 119(1):296-307
  • Liu H, Zhang YL, Hahn T, Thomas J, Wetzler M, Wang ES, Hernandez L, Ross M, Chen GL, McCarthy PL. Optimizing the Timing of Allogeneic Blood or Marrow Transplantation (BMT) in a Prospective Cohort of Relapsed or Refractory Acute Myeloid Leukemia (AML). Blood 2011; 118(21):1338
  • Luger SM, Ringden O, Zhang M-J, Perez WS, Bishop MR, Bornhauser M, Bredeson CN, Cairo MS, Copelan EA, Gale RP, Giralt SA, Gulbas Z, Gupta V, Hale GA, Lazarus HM, Lewis VA, Lill MC, McCarthy PL, Weisdorf DJ, Pulsipher MA . Similar outcomes using myeloablative vs reduced-intensity allogeneic transplant preparative regimens for AML or MDS. Bone marrow transplantation 2012; 47(2):203-211
  • Pederson KA, Rizzo JD, Hahn T, Lee SJ, McCarthy PL, Ammi MS, Denzen EM, Drexler R, Flesch SM, James H, Omondi NA, Pedersen TL, Murphy EA, Majhail NS. Patient and Family Out-of-Pocket Costs of Allogeneic Hematopoietic Cell Transplantation (HCT): A Pilot Study. Biology of blood and marrow transplantation 2012; 18(2 Suppl.):S237-S238
  • Oliansky DM, Camitta B, Gaynon P, Nieder ML, Parsons SK, Pulsipher MA, Dillon H, Ratko TA, Wall D, McCarthy PL Jr, Hahn T. Role of cytotoxic therapy with hematopoietic stem cell transplantation in the treatment of pediatric acute lymphoblastic leukemia: update of the 2005 evidence-based review. Biology of blood and marrow transplantation 2012; 18(4):505-522
  • Capitano ML, Nemeth M, McCarthy P, Repasky EA. A novel warming strategy for improving neutrophil recovery following total body irradiation. Proceedings of the American Association for Cancer Research Annual Meeting 2011; 52:Abstract #575
  • Ballen KK, Klein JP, Pedersen TL, Bhatla D, Duerst R, Kurtzberg J, Lazarus HM, LeMaistre CF, McCarthy P, Mehta P, Palmer J, Setterholm M, Wingard JR, Joffe S, Parsons SK, Switzer GE, Lee SJ, Rizzo JD, Majhail NS. Relationship of race/ethnicity and survival after single umbilical cord blood transplantation for adults and children with leukemia and myelodysplastic syndromes. Biology of blood and marrow transplantation 2012; 18(6):903-912
  • Ludwig H, Durie BGM, McCarthy P, Palumbo A, San Miguel J, Barlogie B, Morgan G, Sonneveld P, Spencer A, Andersen KC, Facon T, Stewart KA, Einsele H, Mateos M-V, Wijermans P, Waage A, Beksac M, Richardson PG, Hulin C, Niesvizky R, Lokhorst H, Landgren O, Leif Bergsagel P, Orlowski R, Hinke A, Cavo M, Attal M. IMWG consensus on maintenance therapy in multiple myeloma. Blood 2012; 119(13):3003-3015
  • McCarthy PL, Owzar K, Hofmeister CC, Hurd DD, Hassoun H, Richardson PG, Giralt S, Stadtmauer EA, Weisdorf DJ, Vij R, Moreb JS, Callander NS, Van Besien K, Gentile T, Isola L, Maziarz RT, Gabriel DA, Bashey A, Landau H, Martin T, Qazilbash MH, Levitan D, McClune B, Schlossman R, Hars V, Postiglione J, Jiang C, Bennett E, Barry S, Bressler L, Kelly M, Seiler M, Rosenbaum C, Hari P, Pasquini MC, Horowitz MM, Shea TC, Devine SM, Anderson KC, Linker C. Lenalidomide after stem-cell transplantation for multiple myeloma. New England journal of medicine 2012; 366(19):1770-1781
  • Abluwalia MS, Anne N, Smiley SL, Battiwalla M, Schiff MD, Loud PA, Hahn T, Bullard DKM, McCarthy PL. Medical management of pneumatosis intestinalis in patients undergoing allogeneic blood and marrow transplantation. Biology of blood and marrow transplantation 2009; 15(2 Suppl. 2):312
  • Hahn T, Dunford L, Butler B, Stento N, Smiley S, Battiwalla M, McCarthy PL. A Comparison of Measured vs. Calculated Creatinine Clearance and Their Lack of Association with Renal Regimen Related Toxicity after Autologous and Allogeneic BMT. Biology of blood and marrow transplantation 2008; 14(2 Suppl. 2):306
  • Hahn T, Jensen S, Lopez F, Zevon M, Tan W, Wilding G, Paddon C, White J, Thomas J, Battiwalla M, Smiley SL, McCarthy PL. Psychosocial Factors and Overall Survival After Autologous and Allogeneic BMT. Biology of blood and marrow transplantation 2009; 15(2 Suppl. 2):147
  • Hahn T, Smiley SL, Tan W, Wilding G, Thomas J, Fassl K, Wright C, Battiwalla M, McCarthy PL. Physical Performance Factors and Overall Survival After Autologous and Allogeneic BMT. Biology of blood and marrow transplantation 2009; 15(2 Suppl. 2):97
  • Ringden OTH, Pavletic S, Anasetti C, Barrett JA, Wang T, Antin JH, Di Bartolomeo P, Bolwell BJ, Bredeson C, Cairo MS, Gale RP, Giralt S, Hahn T, Hale GA, Halter J, Jagasia M, Litzow MR, Locatelli F, McCarthy PL, Cowan MJ, Petersdorf EW, Russel JA, Schiller GJ, Schouten H, Tallman MS, Verdonck LF, Wiley JM, Wingard JR, Horowitz MM, Arora M. Similar graft-versus-leukemia effect using matched unrelated donors, compared to HLA-identical siblings for hematopoietic stem cell transplantation. Biology of blood and marrow transplantation 2008; 14(2 Suppl. 2):33
  • West K, Brown K, Paplbam P, Privitere L, Syta M, Battiwalla M, Smiley S, McCurthy PL. High Rate of Revaccination in Allogeneic and Early Autologous Stem Cell Transplantation-Results of a Single Center Compliance Tracking Survey. Biology of blood and marrow transplantation 2008; 14(2 Suppl. 2):469
  • Sardesai SD, Tan W, Ford LA, Deeb G, Block AMW, Sait SNJ, McCarthy PL, Vigil CE, Griffiths EA, Thompson JE, Wang ES, Wallace PK, Wetzler M. Predicting outcome based on minimal residual disease (MRD) using multiparameter flow cytometry (FC) in acute myeloid leukemia (AML) patients (Pts) : ASCO Meeting Abstracts Part 1. Journal of clinical oncology 2012; 30(15 Suppl.):Abstract #6565
  • Ballen KK, Woolfrey AE, Zhu X, Ahn KW, Wirk B, Arora M, George B, Savani BN, Bolwell B, Porter DL, Copelan E, Hale G, Schouten HC, Lewis I, Cahn JY, Halter J, Cortes J, Kalaycio ME, Antin J, Aljurf MD, Carabasi MH, Hamadani M, McCarthy P, Pavletic S, Gupta V, Deeg HJ, Maziarz RT, Horowitz MM, Saber W. Allogeneic hematopoietic cell transplantation for advanced polycythemia vera and essential thrombocythemia. Biology of blood and marrow transplantation 2012; 18(9):1446-1454
  • Khoury HJ, Kukreja M, Goldman JM, Wang T, Halter J, Arora M, Gupta V, Rizzieri DA, George B, Keating A, Gale RP, Marks DI, McCarthy PL, Woolfrey A, Szer J, Giralt SA, Maziarz RT, Cortes J, Horowitz MM, Lee SJ. Prognostic factors for outcomes in allogeneic transplantation for CML in the imatinib era: a CIBMTR analysis. Bone marrow transplantation 2012; 47(6):810-816
  • Ringden O, Shrestha S, Da Silva GT, Zhang M-J, Dispenzieri A, Remberger M, Kamble R, Freytes CO, Gale RP, Gibson J, Gupta V, Holmberg L, Lazarus H, McCarthy P, Meehan K, Schouten H, Milone GA, Lonial S, Hari PN. Effect of acute and chronic GVHD on relapse and survival after reduced-intensity conditioning allogeneic transplantation for myeloma. Bone marrow transplantation 2012; 47(6):831-837
  • Oliansky DM, Larson RA, Weisdorf D, Dillon H, Ratko TA, Wall D, McCarthy PL Jr, Hahn T. The role of cytotoxic therapy with hematopoietic stem cell transplantation in the treatment of adult acute lymphoblastic leukemia: update of the 2006 evidence-based review. Biology of blood and marrow transplantation 2012; 18(1):16-17
  • Wang ES, Zeidan A, Tan W, Wilding GE, Ford LA, Wallace PK, Hahn TE, Battiwalla M, McCarthy PL, Wetzler M. Cytoreduction with gemtuzumab ozogamicin and cytarabine prior to allogeneic stem cell transplant for relapsed/refractory acute myeloid leukemia. Leukemia and lymphoma 2012; 53(10):2085-2088